Venture Valuation specializes in independent assessments and valuations of companies in high-growth markets, such as biotechnology, life sciences and medical technology.
Products, services, technology
Product valuations => licensing deals, future values,
Company valuations => financing / fundraising and investments,
Biotechgate => asset licensing, target list, investors search, licensing benchmarking
Venture Valuation is looking for cooperation partners for both, the valuation business as well as Biotechgate. Existing partners and clients include European Investment Bank, Novartis Venture Fund, SwedenBIO, California Life Science Association (CLSA), BIOTECanada, Ausbiotech, BIO.NRW and many more.